0001345281-20-000006.txt : 20201120 0001345281-20-000006.hdr.sgml : 20201120 20201120170739 ACCESSION NUMBER: 0001345281-20-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canarick Robert CENTRAL INDEX KEY: 0001382218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 201333337 MAIL ADDRESS: STREET 1: C/O INTEGRATED BIOPHARMA, INC. STREET 2: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-11-04 0 0001016504 INTEGRATED BIOPHARMA INC inbp 0001382218 Canarick Robert 225 LONG AVENUE BLDG 15 HILLSIDE NJ 07205 1 0 0 0 Stock Option (right to buy) 0.65 2020-11-04 4 A 0 50000 0 A 2030-11-04 Common Stock 50000 50000 D The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020 and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020. /s/ Robert Canarick 2020-11-20